Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.73 HKD | 0.00% | -1.35% | -18.89% |
Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 660M 84.3M | Sales 2022 | 448M 57.26M | Capitalization | 506M 64.63M |
---|---|---|---|---|---|
Net income 2021 | -122M -15.59M | Net income 2022 | -120M -15.34M | EV / Sales 2021 | 1.14 x |
Net Debt 2021 | 436M 55.71M | Net Debt 2022 | 427M 54.61M | EV / Sales 2022 | 2.08 x |
P/E ratio 2021 |
-2.62
x | P/E ratio 2022 |
-4.2
x | Employees | 662 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.06% |
1 week | -1.35% | ||
Current month | -12.05% | ||
1 month | -9.88% | ||
3 months | -16.09% | ||
6 months | -31.78% | ||
Current year | -18.89% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Hang Woon Ma
SAM | Sales & Marketing | - | - |
Pui Hung
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwok Wah Ho
BRD | Director/Board Member | 65 | 15-06-11 |
Lim Kin Leung
BRD | Director/Board Member | 70 | 15-06-11 |
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.73 | 0.00% | 13 000 |
24-04-29 | 0.73 | -2.67% | 402,500 |
24-04-26 | 0.75 | 0.00% | 70,000 |
24-04-25 | 0.75 | 0.00% | 0 |
24-04-24 | 0.75 | +1.35% | 208,000 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 10:55 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.89% | 36.85M | |
+37.08% | 6.01B | |
-17.43% | 4.4B | |
-9.46% | 3.17B | |
+0.51% | 3.07B | |
-3.53% | 2.51B | |
+41.15% | 1.88B | |
-5.15% | 1.73B | |
+0.09% | 1.65B | |
-10.38% | 1.58B |
- Stock Market
- Equities
- 1498 Stock